Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lineage fate of ductular reactions in liver injury and carcinogenesis
Simone Jörs, … , Jens T. Siveke, Fabian Geisler
Simone Jörs, … , Jens T. Siveke, Fabian Geisler
Published April 27, 2015
Citation Information: J Clin Invest. 2015;125(6):2445-2457. https://doi.org/10.1172/JCI78585.
View: Text | PDF
Research Article Hepatology

Lineage fate of ductular reactions in liver injury and carcinogenesis

  • Text
  • PDF
Abstract

Ductular reactions (DRs) are observed in virtually all forms of human liver disease; however, the histogenesis and function of DRs in liver injury are not entirely understood. It is widely believed that DRs contain bipotential liver progenitor cells (LPCs) that serve as an emergency cell pool to regenerate both cholangiocytes and hepatocytes and may eventually give rise to hepatocellular carcinoma (HCC). Here, we used a murine model that allows highly efficient and specific lineage labeling of the biliary compartment to analyze the histogenesis of DRs and their potential contribution to liver regeneration and carcinogenesis. In multiple experimental and genetic liver injury models, biliary cells were the predominant precursors of DRs but lacked substantial capacity to produce new hepatocytes, even when liver injuries were prolonged up to 12 months. Genetic modulation of NOTCH and/or WNT/β-catenin signaling within lineage-tagged DRs impaired DR expansion but failed to redirect DRs from biliary differentiation toward the hepatocyte lineage. Further, lineage-labeled DRs did not produce tumors in genetic and chemical HCC mouse models. In summary, we found no evidence in our system to support mouse biliary-derived DRs as an LPC pool to replenish hepatocytes in a quantitatively relevant way in injury or evidence that DRs give rise to HCCs.

Authors

Simone Jörs, Petia Jeliazkova, Marc Ringelhan, Julian Thalhammer, Stephanie Dürl, Jorge Ferrer, Maike Sander, Mathias Heikenwalder, Roland M. Schmid, Jens T. Siveke, Fabian Geisler

×

Figure 2

DRs arise from the biliary HNF1β+ compartment in a broad range of liver injury models.

Options: View larger image (or click on image) Download as PowerPoint
DRs arise from the biliary HNF1β+ compartment in a broad range of liver ...
(A) Seven days after tamoxifen injection, R26Tom Hnf1b-CreER mice were subjected to 2 to 3 weeks of various short-term liver injury models (DDC diet, BDL, MDA, CDE diet). For fate mapping of DRs in MDR2-deficient mice, Mdr2–/– R26Tom Hnf1b-CreER animals received tamoxifen at week 3 to 4 and were analyzed at week 8. (B) In all models, characteristic DRs were assessed by IHC for CK19. Regardless of the mode of injury co-IF analysis revealed tdTom expression in most CK19+ cells, while expression of tdTom in HNF4α+ hepatocytes was consistently only observed in the CDE model (yellow arrows). (C) Colocalization (mean value ± SEM) of tdTom+/CK19+ and tdTom+/HNF4α+ cells expressed as percentage colocalization (DDC diet, n = 9; BDL, n = 4; MDA, n = 4; Mdr2–/–, n = 4; CDE diet, n = 5). n.d., not detected. Scale bar: 100 μm (first and third rows); 20 μm (second, fourth, and fifth rows).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts